Douglas Research Insights

Douglas Research Insights

Archimed Group Seeks Delisting of Jeisys Medical Through Stock Exchange

Douglas Kim's avatar
Douglas Kim
Aug 19, 2024
∙ Paid
  • Jeisys Medical announced that it has decided to exchange shares with Syracus Subco, its largest shareholder. The stock exchange ratio between Syracus Subco and Jeisys Medical is 1 to 1.3575606.

  • The exchange date is 23 October. Through this stock exchange, Archimed Group (owner of Syracus Subco) seeks to delist Jeisys Medical (287410 KS).

  • Jeisys Medical also announced that it plans to cancel 1,075,838 common shares, representing 1.4% of its outstanding shares.

User's avatar

Continue reading this post for free, courtesy of Douglas Kim.

Or purchase a paid subscription.
© 2026 Douglas Kim · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture